Meeting
2014 Genitourinary Cancers Symposium
Stage I testicular tumor: How frequently to scan?
Authors
Sindhu Ramamurthy
Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, United Kingdom
Sindhu Ramamurthy , Najibah Mahtab , Helen Showler , John A. Frew , Ian D. Pedley , Ashraf Azzabi , Jolene Brown , Rhona Margaret McMenemin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Penile, Urethral, and Testicular Cancers
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 380)
DOI
10.1200/jco.2014.32.4_suppl.380
Abstract #
380
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
First Author: Stephanie Anne Holler Howard
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2015 Genitourinary Cancers Symposium
A review of clinical stage 1 testicular cancer mortality in a high-volume center.
First Author: Sophia C. Kamran
Poster
2021 ASCO Annual Meeting
Outcomes of patients with germ cell tumors diagnosed with stage I disease who subsequently received high dose chemotherapy (HDCT) with peripheral stem cell transplant (PBSCT) following failure of initial therapy for metastatic disease: The Indiana University experience.
First Author: Stephen B Benzinger